Entities / Company
Idorsia.
company in Allschwil, Switzerland
- Reports this week
- 0
- Active events
- 0
- Connections
- 18
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
-
Idorsia, a Swiss biopharmaceutical company, was spun off following an acquisition by Johnson & Johnson from Actelion.Some support1 report
-
Nike forecasts a surprise drop in annual revenue, while Aker sells Cognite and Idorsia appoints a new CEO.Some support1 report
-
Idorsia appoints Roland Wandeler as CEO, who previously held senior roles at Morphosys and Amgen.Some support3 reports
No events began in the chosen period. Widen it, or reset.
Around Idorsia this week
News at the entities that move Idorsia most-
Johnson & Johnson TransactionalP&G, Johnson & Johnson, and Coca-Cola are noted as dividend growth stocks, coinciding with SEC requirements for fiduciaries to prioritize interests.Moves Idorsia
-
Switzerland Shared contextECB has established swap line arrangements with central banks, with the ECB President leading central bank operations.Moves Idorsia
Connections
The 7 strongest of 18, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Roland Structural
Roland is appointed as CEO of Idorsia, tasked with leading the company's growth and operational direction.
-
Jean-Paul Clozel Structural
Jean-Paul Clozel served and is forecast to serve as the CEO of Idorsia.
-
Johnson & Johnson Transactional
Idorsia was acquired by Johnson & Johnson, leading to its subsequent spin-off.
-
Actelion Structural
Idorsia was established as a spin-off entity from Actelion.
-
Allschwil Shared context
Idorsia is headquartered in Allschwil.
-
Switzerland Shared context
Idorsia is a biopharmaceutical company operating within Switzerland.
-
Aker Mentioned together
Co-mention evidence suggests potential co-existence, though the available snapshot only details Idorsia's internal leadership appointment.
History
Events by the month they beganJuly 2026
3 events- Idorsia, a Swiss biopharmaceutical company, was spun off following an acquisition by Johnson & Johnson from Actelion.
- Nike forecasts a surprise drop in annual revenue, while Aker sells Cognite and Idorsia appoints a new CEO.
- Idorsia appoints Roland Wandeler as CEO, who previously held senior roles at Morphosys and Amgen.